ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

Current StatisticsSubscribe to Current Statistics

Parth Aluminium

Vysali Pharmaceuticals Vysali Pharmaceuticals, an existing dividend paying company manufacturing a wide nuige of pharmaceutical formulations, is setting up a bulk drugs plant for the manufacture of semi synthetic penicillins, antibiotics and antibacterials in a phased manner, expecting to earn a reasonable profit working at 10 per cent, 30 per cent and 45 per cent of installed capacity in the first, second and third year of operations. The implementation of the first phase will be completed by September 1992 and the entire project by September 1993, The company expects to exploit the vast potential in the domestic and export market for the complete range of injectibte penicillins and have received enquiries already From Nigeria, Ghana, Zaire, and Abu Dhabi. Promoted by A D Krishnan and Savithry Krishnan, both having had 15 years of experience in pharmaceutical companies, the project in Alwaye village, Ernakulam District, Kerala, will source indigenous machinery and process equipment. The project appraisal has been done by Kerala State Industrial Development Corporation, with its cost estimated at Rs 493 lakh. The public issue of 30,00,000 equity shares of Rs 10 each at par, aggregating Rs 300 lakh, opens on July 6.

Marmagoa Steel

 THE CAPITAL MARKET Marmagoa Steel MARMAGOA STEEL is issuing 1,05,32,672 equity shares of Rs 10 each at par Out of the issue 50,32,672 shares are reserved for firm allotment

Indo-Maxwell

 THE CAPITAL MARKET Marmagoa Steel MARMAGOA STEEL is issuing 1,05,32,672 equity shares of Rs 10 each at par Out of the issue 50,32,672 shares are reserved for firm allotment

Shree Rajasthan Syntex

 THE CAPITAL MARKET Marmagoa Steel MARMAGOA STEEL is issuing 1,05,32,672 equity shares of Rs 10 each at par Out of the issue 50,32,672 shares are reserved for firm allotment

CT Cotton Yarn

 THE CAPITAL MARKET Marmagoa Steel MARMAGOA STEEL is issuing 1,05,32,672 equity shares of Rs 10 each at par Out of the issue 50,32,672 shares are reserved for firm allotment

Pages

Back to Top